Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins

about

Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins

Item

http://www.wikidata.org/entity/Q57746174

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2012

@uk

name

Pharmacological and Host Consi ...... of Therapy with Echinocandins

@en

Pharmacological and Host Consi ...... of Therapy with Echinocandins

@nl

type

Item

label

Pharmacological and Host Consi ...... of Therapy with Echinocandins

@en

Pharmacological and Host Consi ...... of Therapy with Echinocandins

@nl

prefLabel

Pharmacological and Host Consi ...... of Therapy with Echinocandins

@en

Pharmacological and Host Consi ...... of Therapy with Echinocandins

@nl

P1476

Pharmacological and Host Consi ...... of Therapy with Echinocandins

@en

P2093

David C. M. Kong

http://www.w3.org/2001/XMLSchema#string

Monica A. Slavin

http://www.w3.org/2001/XMLSchema#string

Sharon C.-A. Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Echinocandin antifungal drugs

Safety and pharmacokinetics of repeat-dose micafungin in young infants.

Pharmacokinetics of an elevated dosage of micafungin in premature neonates.

Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.

Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.

Population pharmacokinetics of micafungin in neonates and young infants

P2888

s12281-012-0085-y

P304

95-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12281-012-0085-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chin Fen Neoh

P577

2012-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

Farmakologi